Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for BETA BIONICS, INC. Common Stock, $0.0001 par value (BBNX).
- Disclosed ownership: 5.7%.
- Date of event: 31 Dec 2025.
RTW INVESTMENTS, LP - 31 Dec 2025 SCHEDULE 13G/A Report for BETA BIONICS, INC. Common Stock, $0.0001 par value (BBNX)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- BBNX
- Shares outstanding
- 43,859,649 shares
- Disclosed Ownership
- 2,500,000 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 08:29:19 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 5.7% ownership in BETA BIONICS, INC. Common Stock, $0.0001 par value (BBNX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 17 Feb 2026, 08:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 5.7% | 2,500,000 | 0 | 2,500,000 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 5.7% | 2,500,000 | 0 | 2,500,000 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |